Cdc7-IN-13

• UNSPSC Description:

  Cdc7-IN-13 (compound 84) is a potent CDC7 inhibitor with an IC50 of [1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdc7-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N1)C2=C(C(O[C@H](C3)C)=C(C4=CNN=C4)S2)C3=C1CN5[C@@H](CC5)C

• Molecular Weight:

  356.44

• References & Citations:

  [1]Huang XIanhai, et al. Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer. WO2022055963A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2764866-23-9